Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myriad Genetics (MYGN)
NASDAQ:MYGN
Holding MYGN?
Track your performance easily
See the Price Targets and Ratings of:
MYGN Analyst Ratings
Moderate Buy
5 Buy
3 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MYGN Stock 12 Month Forecast
Average Price Target
$31.67
▲(11.24% Upside)
| Highest Price Target$40.00 | Average Price Target$31.67 | Lowest Price Target$20.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Assigned
09/19/24
Leerink Partners
Assigned
09/04/24
Wells Fargo
Initiated
08/27/24
Wolfe Research
Reiterated
08/21/24
Piper Sandler
Assigned
08/13/24
Scotiabank
Reiterated
08/13/24
TD Cowen
Assigned
08/07/24
Guggenheim
Reiterated
08/07/24
J.P. Morgan
Reiterated
08/07/24
Jefferies
Downgraded
06/03/24
Raymond James
$25→$28
Buy
-1.65%
Downside
Reiterated
02/28/24
Myriad Genetics price target raised to $28 from $25 at Raymond JamesMyriad Genetics price target raised to $28 from $25 at Raymond James
Goldman Sachs
$28→$31
Buy
8.89%
Upside
Reiterated
01/29/24
Myriad Genetics (MYGN) PT Raised to $31 at Goldman SachsGoldman Sachs analyst Matthew Sykes raised the price target on Myriad Genetics (NASDAQ: MYGN) to $31.00 (from $28.00) while maintaining a Buy rating.
Bank of America Securities
$21→$18
Sell
-36.78%
Downside
Reiterated
10/20/23
Myriad Genetics (MYGN) PT Lowered to $18 at BofA SecuritiesBofA Securities analyst Derik de Bruin lowered the price target on Myriad Genetics (NASDAQ: MYGN) to $18.00 (from $21.00) while maintaining a Underperform rating.
Best Analysts Covering Myriad Genetics
Which Analyst Should I Follow If I Want to Buy MYGN and Sell After:
1 Month
xxx
Success Rate
5/13 ratings generated profit
Average Return
-4.49%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of -4.49% per trade.
3 Months
xxx
Success Rate
8/13 ratings generated profit
Average Return
-1.25%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of -1.25% per trade.
1 Year
Success Rate
6/7 ratings generated profit
Average Return
+21.69%
reiterated a buy rating 8 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +21.69% per trade.
2 Years
xxx
Success Rate
6/7 ratings generated profit
Average Return
+25.81%
reiterated a xxx
rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 85.71% of your transactions generating a profit, with an average return of +25.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MYGN Analyst Recommendation Trends
Rating
Mar 24
May 24
Jun 24
Aug 24
Sep 24
Strong Buy
0
0
0
0
0
Buy
2
2
3
8
8
Hold
5
7
3
5
3
Sell
1
1
1
3
3
Strong Sell
0
0
0
0
0
total
8
10
7
16
14
Each month's total comprises the sum of three months' worth of ratings.
MYGN Financial Forecast
MYGN Stock Forecast FAQ
What is MYGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Myriad Genetics’s 12-month average price target is $31.67.
What is MYGN’s upside potential, based on the analysts’ average price target?
Myriad Genetics has 11.24% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MYGN a Buy, Sell or Hold?
Myriad Genetics has a consensus rating of Moderate Buy which is based on 5 buy ratings, 3 hold ratings and 1 sell ratings.
What is Myriad Genetics’s price target?
The average price target for Myriad Genetics is $31.67. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $40.00 ,the lowest forecast is $20.00. The average price target represents 11.24% Increase from the current price of $28.47.
The highest analyst price target is $40.00 ,the lowest forecast is $20.00. The average price target represents 11.24% Increase from the current price of $28.47.
What do analysts say about Myriad Genetics?
Myriad Genetics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of MYGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.